Email ID
Password
Sign me in automatically next time
Biovail acquires worldwide rights to tetrabenazine
19 May 2009
Sukaina Virji

sukaina.virji@informa.com

Biovail is to acquire worldwide development and commercialisation rights to the entire portfolio of tetrabenazine products held by its Irish originator Cambridge Laboratories for $230 million. The acquisition includes Xenazine/Nitoman (tetrabenazine...



Please Login to read the full article.
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK Promote your vacancy here
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36